Although most people do not need to fear the rare mycoses described in this section, those with certain specific diseases may be at risk. Allergic bronchopulmonary aspergillosis (ABPA) and Aspergilloma are two rare lung diseases that mainly affect patients with cystic fibrosis and chronic asthma.
ABPA is caused by mold parts of the genus Aspergillus, particularly Aspergillus fumigatus, which grows in plant pots, compost and animal cages, and also in foodstuffs. Ten to 30 percent of cystic fibrosis patients and 1 to 2 percent of asthmatics are affected by this disease, which if left untreated can cause severe lung damage such as reduced lung volume or scar formation.
In conclusion, although rare, allergic bronchopulmonary aspergillosis and Aspergilloma can pose a health threat to patients with cystic fibrosis and chronic asthma. To prevent the occurrence of these diseases or to manage them properly, constant attention to one's health and excellent cooperation with one's primary care physician is essential.
The threat of rare mycoses to those with pre-existing diseases